681 related articles for article (PubMed ID: 25443437)
1. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
[TBL] [Abstract][Full Text] [Related]
3. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
[TBL] [Abstract][Full Text] [Related]
4. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
[TBL] [Abstract][Full Text] [Related]
5. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
6. The interaction of serum testosterone levels and androgen receptor CAG repeat polymorphism on the risk of erectile dysfunction in aging Taiwanese men.
Liu CC; Lee YC; Tsai VF; Cheng KH; Wu WJ; Bao BY; Huang CN; Yeh HC; Tsai CC; Wang CJ; Huang SP
Andrology; 2015 Sep; 3(5):902-8. PubMed ID: 26216079
[TBL] [Abstract][Full Text] [Related]
7. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
Maggi M; Filippi S; Vignozzi L; Rastrelli G
Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
[TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
[TBL] [Abstract][Full Text] [Related]
9. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
10. Androgen Receptor Polymorphism and Female Sexual Function and Desire.
Wåhlin-Jacobsen S; Flanagan JN; Pedersen AT; Kristensen E; Arver S; Giraldi A
J Sex Med; 2018 Nov; 15(11):1537-1546. PubMed ID: 30415810
[TBL] [Abstract][Full Text] [Related]
11. Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
Int J Endocrinol; 2013; 2013():816740. PubMed ID: 24454369
[TBL] [Abstract][Full Text] [Related]
12. Tri-nucleotide consortium of androgen receptor is associated with low serum FSH and testosterone in asthenospermic men.
Khan HL; Bhatti S; Abbas S; Khan YL; Aslamkhan M; Gonzalez RMM; Gonzalez GR; Aydin HH; Trinidad MS
Syst Biol Reprod Med; 2018 Apr; 64(2):112-121. PubMed ID: 29083935
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
14. Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.
Rastrelli G; Giovannini L; Calogero AE; Gianfrilli D; Serra E; Pizzocaro A; Giagulli VA; Motta G; Vancieri G; Sperandio A; Andò S; Selice R; Luca G; Cocchiara F; Canale D; Maggi M
J Endocrinol Invest; 2016 Jun; 39(6):695-708. PubMed ID: 27037688
[TBL] [Abstract][Full Text] [Related]
15. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
16. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
Stanworth RD; Akhtar S; Channer KS; Jones TH
Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
[TBL] [Abstract][Full Text] [Related]
17. Influence of Androgen Receptor Gene CAG and GGC Polymorphisms on Male Sexual Function: A Cross-Sectional Study.
Tirabassi G; Corona G; Falzetti S; Delli Muti N; Maggi M; Balercia G
Int J Endocrinol; 2016; 2016():5083569. PubMed ID: 28243253
[No Abstract] [Full Text] [Related]
18. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
20. [65-month testosterone replacement therapy for androgen deficiency-induced ED: a case report and review of the literature].
Jiang T; Zheng L; Sun DC; Li QL; Zhang ZW; Wang FP; Wang QF; Jiang H
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):152-5. PubMed ID: 24520668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
